Beth Jantzen

CIK: 0001633940

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNBX

APPLIED DNA SCIENCES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

BNBX
BNB PLUS CORP.
Dec 15, 2025
Award(A)
Incentive Stock Option (right to buy)
Direct
42.2K shares-
BNBX
BNB PLUS CORP.
Dec 15, 2025
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
42.2K shares-
BNBX
APPLIED DNA SCIENCES INC
Oct 17, 2025
Award(A)
Direct
18.7K shares-

		Type	Shares	Price		Ownership
Dec 15, 2025	BNBX BNB PLUS CORP.	Award(A) Incentive Stock Option (right to buy)	42,194	-	-	Direct
Dec 15, 2025	BNBX BNB PLUS CORP.	Award(A) Non-Qualified Stock Option (right to buy)	42,194	-	-	Direct
Oct 17, 2025	BNBX APPLIED DNA SCIENCES INC	Award(A)	18,691	-	-	Direct

1-3 of 3 transactions

About Jantzen Beth

Jantzen Beth (SEC CIK 0001633940) files insider reports with the SEC as Chief Financial Officer of APPLIED DNA SCIENCES INC (BNBX).

Signal8 holds 2 ownership filings by Jantzen Beth, all Form 4s, filed between Oct 20, 2025 and Dec 16, 2025. Those filings report 3 transactions, from Oct 17, 2025 to Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Jantzen Beth's filings is in STONY BROOK, NY.

Recent filings by Jantzen Beth

Dec 15, 2025: Grants or awards of BNBX derivative securities (2 lines, Form 4, code A).
Oct 17, 2025: Grant or award of BNBX shares (Form 4, code A).

Other insiders filing for APPLIED DNA SCIENCES INC (BNBX)

Shorten Richard Lee Jr., Director
Larsen Todd, Director
Lee Lok, Director
KGPLA Holdings LLC, 10% Owner
Haft James, Director
Shorrock Clay, Chief Executive Officer

How to read Form 4 transaction codes